UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

3D printed rectal swabs for assessing the gut microbiome, metabolome and inflammation

Scientific reports, 2024-07, Vol.14 (1), p.16613-7, Article 16613

2024

Volltextzugriff (PDF)

Axonally derived neuregulin-1 is required for remyelination and regeneration after nerve injury in adulthood

The Journal of neuroscience, 2011-03, Vol.31 (9), p.3225-3233

2011

Volltextzugriff (PDF)

Identification of a Sub-Clinical Salmonella spp. Infection in a Dairy Cow Using a Commercially Available Stool Storage Kit

Animals (Basel), 2023-09, Vol.13 (17), p.2807

2023

Volltextzugriff (PDF)

The Pathophysiology of Impulse control Disorders in Parkinson Disease

Behavioural neurology, 2013-01, Vol.26 (4), p.237-244

2013

Volltextzugriff (PDF)

3165 The Great Masquerade

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S1696-S1696

2019

Volltextzugriff (PDF)

2639 A Curious Case of Abdominal Pain

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S1452-S1452

2019

Volltextzugriff (PDF)

P49 The South Asian inflammatory bowel disease (IBD) phenotype: ethnic differences demonstrated through analysis of the UK IBD BioResource database

Gut, 2023-06, Vol.72 (Suppl 2), p.A71-A71

2023

Volltextzugriff (PDF)

Mo1780 COMPARISON OF FAECAL CALPROTECTIN PERFORMANCE BETWEEN OLDER AND YOUNGER ADULTS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1108-S-1108

2024

Volltextzugriff (PDF)

Sa1889 3D PRINTED RECTAL SWABS FOR ASSESSING THE GUT MICROBIOME, METABOLOME, AND INFLAMMATION

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-566-S-567

2024

Volltextzugriff (PDF)

Mo1870 CONSISTENT APPROACH TO IBD TREATMENT ACROSS SOUTH ASIAN AND WHITE ETHNICITIES IN THE UK DESPITE PHENOTYPIC VARIATIONS: A STUDY OF 33,157 PATIENTS USING THE IBD BIORESOURCE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1152-S-1153

2024

Volltextzugriff (PDF)

Sa1871 THE COMPOSITION AND FUNCTION OF THE GUT MICROBIOTA IN A TREATMENT NAIVE INCEPTION COHORT OF INFLAMMATORY BOWEL DISEASE (IBD) CAN ACCURATELY DIFFERENTIATE IBD PHENOTYPE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-559-S-559

2024

Volltextzugriff (PDF)

SAT-089-Evaluating the impact of non-selective beta-blocker use in decompensated cirrhosis based on setting of patient care

Journal of hepatology, 2019-04, Vol.70 (1), p.e667-e667

2019

Volltextzugriff (PDF)

Identification of a Sub-Clinical ISalmonella/I spp. Infection in a Dairy Cow Using a Commercially Available Stool Storage Kit

Animals (Basel), 2023-09, Vol.13 (17)

2023

Volltextzugriff (PDF)

The pathophysiology of impulse control disorders in Parkinson disease

Behavioural neurology, 2013, Vol.26 (4), p.237-244

2013

Volltextzugriff (PDF)

P75 Vaccine-induced antibody responses against influenza are diminished in infliximab and tofacitinib-treated IBD patients and correlate with responses to COVID-19 vaccination

Gut, 2023-06, Vol.72 (Suppl 2), p.A88-A88

2023

Volltextzugriff (PDF)

Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine

Gastroenterology (New York, N.Y. 1943), 2023-02, Vol.164 (2), p.300-303.e3

2023

Volltextzugriff (PDF)

Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-594-S-595

2022

Volltextzugriff (PDF)

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID‐19 pandemic: the PREPARE‐IBD multicentre cohort study

Alimentary pharmacology & therapeutics, 2022-11, Vol.56 (10), p.1460-1474

2022

Volltextzugriff (PDF)

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

The lancet. Gastroenterology & hepatology, 2021-04, Vol.6 (4), p.271-281

2021

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(8)
Life Sciences & Biomedicine
(7)
Humans
(6)
Gastroenterology & Hepatology
(4)
Inflammatory Bowel Disease
(4)
Inflammatory Bowel Diseases
(4)
Adult
(3)
Covid-19
(3)
Female
(3)
Male
(3)
Middle Aged
(3)
Animals
(2)
Case-Control Studies
(2)
Cohort Studies
(2)
Colitis, Ulcerative - Diagnosis
(2)
Covid-19 Vaccines
(2)
Dairy Cattle
(2)
Deep Brain Stimulation
(2)
Inflammatory Bowel Diseases - Drug Therapy
(2)
Infliximab
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

3D printed rectal swabs for assessing the gut microbiome, metabolome and inflammation

Axonally derived neuregulin-1 is required for remyelination and regeneration after nerve injury in adulthood

Identification of a Sub-Clinical Salmonella spp. Infection in a Dairy Cow Using a Commercially Available Stool Storage Kit

The Pathophysiology of Impulse control Disorders in Parkinson Disease

3165 The Great Masquerade

2639 A Curious Case of Abdominal Pain

P49 The South Asian inflammatory bowel disease (IBD) phenotype: ethnic differences demonstrated through analysis of the UK IBD BioResource database

Mo1780 COMPARISON OF FAECAL CALPROTECTIN PERFORMANCE BETWEEN OLDER AND YOUNGER ADULTS

Sa1889 3D PRINTED RECTAL SWABS FOR ASSESSING THE GUT MICROBIOME, METABOLOME, AND INFLAMMATION

Mo1870 CONSISTENT APPROACH TO IBD TREATMENT ACROSS SOUTH ASIAN AND WHITE ETHNICITIES IN THE UK DESPITE PHENOTYPIC VARIATIONS: A STUDY OF 33,157 PATIENTS USING THE IBD BIORESOURCE

Sa1871 THE COMPOSITION AND FUNCTION OF THE GUT MICROBIOTA IN A TREATMENT NAIVE INCEPTION COHORT OF INFLAMMATORY BOWEL DISEASE (IBD) CAN ACCURATELY DIFFERENTIATE IBD PHENOTYPE

SAT-089-Evaluating the impact of non-selective beta-blocker use in decompensated cirrhosis based on setting of patient care

Identification of a Sub-Clinical ISalmonella/I spp. Infection in a Dairy Cow Using a Commercially Available Stool Storage Kit

The pathophysiology of impulse control disorders in Parkinson disease

P75 Vaccine-induced antibody responses against influenza are diminished in infliximab and tofacitinib-treated IBD patients and correlate with responses to COVID-19 vaccination

Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine

Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID‐19 pandemic: the PREPARE‐IBD multicentre cohort study

Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

COVID-19 Vaccine-Induced Antibody and T Cell Responses in Immunosuppressed Patients with Inflammatory Bowel Disease After the Third Vaccine Dose

COVID-19 Vaccine-Induced Antibody Responses are Impaired in IBD Patients Treated with Infliximab or Tofacitinib, but not Thiopurines, Ustekinumab or Vedolizumab

Suchergebnisse filtern